Login
Super Investors Gilfoyle Management LLC
GM

Gilfoyle Management LLC

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Portfolio value
$49.2K
Positions
9
Quarter ended
September 30, 2023
Filed
October 12, 2023

Reported portfolio value by quarter (3 quarters reported)

$49.2K $7.5K
Q1 23 Q2 23 Q3 23

$7.5K in Q1 2023 → $49.2K now. Hover for any quarter.

Holdings

As reported for the quarter ended September 30, 2023. Activity is the change in share count since the prior quarter's filing.

Holding % of portfolio Activity Shares Value
Tesla, Inc. 25.6% Added 380% 48 $12.6K
Apple Inc 13.3% New 150 $6.52K
Crispr Therapeutics Ag 13.0% Added 50% 150 $6.38K
AE Ark ETF Trust 12.0% Trimmed 9.1% 150 $5.9K
Starbucks Corporation 8.8% New 47 $4.35K
I Ishares Inc 8.8% Trimmed 41% 10 $4.34K
IQ Invesco Qqq Tr 7.5% Trimmed 41% 10 $3.67K
The Walt Disney Company 6.6% New 38 $3.26K
AI Anheuser-busch Inbev Sa/nv 4.4% New 39 $2.17K

Timeline of changes

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 2 quarters.

Q3 2023

quarter ended September 30, 2023 · filed October 12, 2023

Company Action Shares changed Value of change % of portfolio
Tesla, Inc. Added +38 +$9.97K 25.6%
Apple Inc New +150 +$6.52K 13.3%
Starbucks Corporation New +47 +$4.35K 8.8%
The Walt Disney Company New +38 +$3.26K 6.6%
I Ishares Inc Trimmed −7 −$3.04K 8.8%
IQ Invesco Qqq Tr Trimmed −7 −$2.57K 7.5%
AI Anheuser-busch Inbev Sa/nv New +39 +$2.17K 4.4%
Crispr Therapeutics Ag Added +50 +$2.13K 13.0%
AE Ark ETF Trust Trimmed −15 −$590 12.0%

Q2 2023

quarter ended June 30, 2023 · filed August 15, 2023

Company Action Shares changed Value of change % of portfolio
AE Ark ETF Trust Added +102 +$4.96K 26.3%
Crispr Therapeutics Ag New +100 +$4.84K 15.9%
IQ Invesco Qqq Tr Added +10 +$4.53K 25.3%
I Ishares Inc Added +10 +$4.41K 24.6%
Tesla Inc New +10 +$2.4K 7.9%

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support